Form 4: Bausch Health Director Acquires Shares

John Paulson, a Director at Bausch Health Companies Inc., acquired 11,574 common shares through restricted stock units.

Summary

• John Paulson, a Director of Bausch Health Companies Inc. (BHC), acquired 11,574 common shares on March 31, 2026.
• These shares were issued as Restricted Stock Units (RSUs) in lieu of cash compensation for his board service for the quarter ending March 31, 2026.
• Each RSU represents a contingent right to one common share of the issuer.
• Following this transaction, Paulson directly owns 371,694 common shares.
• Additionally, through managed funds where he is the controlling person, he may be deemed an indirect beneficial owner of 73,255,869 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine director compensation and share acquisition through RSUs, without significant new financial information or strategic shifts.

Positives

• Director compensation in the form of equity (RSUs) aligns management interests with shareholders.
• Acquisition of shares by a director can signal confidence in the company's future prospects.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Stock Units as compensation is a common practice in the pharmaceutical and healthcare industries to attract and retain executive and director talent, aligning their financial interests with long-term company performance.

Stakeholder Impact

• Shareholders: The issuance of RSUs to directors is a standard compensation practice. The acquisition of shares by a director may be viewed positively as a sign of commitment, but the direct financial impact on existing shareholders from this specific transaction is minimal.

Key Dates

Keywords

Bausch Health, BHC, Form 4, SEC Filing, Insider Trading, Restricted Stock Units, Director Compensation, Equity Awards